Federated Hermes
LJPC

Federated Hermes’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Federated Hermes’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1
Closed -$1K – 2452
2019
Q4 		$1K Buy
+1
New +$6 ﹤0.01% 2201
2017
Q2 		– Sell
-140
Closed -$4K – 2275
2017
Q1 		$4K Buy
+140
New +$3.57K ﹤0.01% 1992

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Federated Hermes's LJPC Position: Q1 2020 in Review

Federated Hermes sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2020, closing a stake of 1 share — an estimated $1K sold.

Federated Hermes first reported a position in LJPC in Q1 2017 and held it in 2 quarters. The position peaked at $4K in Q1 2017. 73 funds tracked by Wall St. Rank hold LJPC as of Q1 2020.

  • Federated Hermes reported no remaining La Jolla Pharmaceutical Company position as of Q1 2020 after selling out during the quarter.
  • Federated Hermes sold 1 La Jolla Pharmaceutical Company share in Q1 2020, an estimated $1K.
  • Federated Hermes first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 2 quarters.
  • Federated Hermes's La Jolla Pharmaceutical Company position peaked at $4K in Q1 2017.
  • 73 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2020.

Based on Federated Hermes's 13F filing for Q1 2020, filed 13 May 2020.